Here’s the latest on how there is a shift in psychiatry toward a new way of thinking about depression, its causes, and therapies.
The profession’s long embrace of the “monoamine hypothesis” — the idea that depression primarily results from abnormal levels of neurotransmitter chemicals in the brain and that drugs can restore the proper balance — is giving way to a more complex understanding and alternative treatments, from ketamine to psychedelics to magnetic stimulation.
Read more
The film Fantastic Fungi is now available on Netflix… check it out!
Read more
Psychedelics are promising treatments for mental illness. Dozens of new startups have sprung up to develop and deliver the drugs to patients in need.
Read more
This study assessed the impact of lifetime psychedelic drug use on mental health in relation to the first strict lockdown adopted by various countries (April-July 2020).
The findings showed that regular users of psychedelic drugs had less psychological stress and some personality differences when compared to occasional users and non-users. This suggests that either the use of psychedelics might be a protective factor itself or people with certain previous traits are more prone to frequently using psychedelic drugs.
Read more
Why journaling is good for you! To some people, keeping a journal might sound hokey. But experts say it's an effective and accessible form of self care.
Read more
From the NYTimes: The psychedelic revolution Is coming, and psychiatry may never be the same.
Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences.
Read more
This piece asks if the embrace of psychedelics could lead to a mental health revolution.
Read more
Author Michael Pollan talks about psychedelics and how they may benefit mental health.
Read more